A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion.
- Status
- COMPLETED
- Phase
- PHASE2
PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy
- Status
- RECRUITING
- Phase
- PHASE2
Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Study of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid Tumours
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
First-in-Human Study of the GDF-15 Neutralizing Antibody Visugromab (CTL-002) in Patients With Advanced Cancer (GDFATHER)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Ipilimumab With Nivolumab for Molecular-selected Patients With Castration-resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
- Status
- RECRUITING
- Phase
- PHASE1
CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pharmacokinetic, Safety, Immunogenicity and Efficacy of CMAB819 and Nivolumab in R/M HNSCC
- Status
- TERMINATED
- Phase
- PHASE1
Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Efficacy in Participants With Metastatic BRAF-mutant Melanoma Treated With Encorafenib With and Without Binimetinib in Combination With Nivolumab and Low-dose Ipilimuma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2